Back to calendar
Ultragenyx Pharmaceutical Inc. (RARE) Earnings
RARE reports earnings on Wednesday, November 4, 2026
earnings report
November 4, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.86
Actual EPS: $-0.90
EPS surprise: 26.09%
Company overview
Market Cap$2.5B
PriceUSD 25.21
EPS (TTM)-5.84
52-week high39.89
52-week low18.29
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees1,371